At FIFARMA, we believe that our members have a responsibility to work to understand the complex factors that affect access to healthcare and medical treatment in our countries and to engage relevant stakeholders in the development of sustainable access to treatment solutions for patients across Latin America. As part of this effort, we frequently commission research reports to better understand the access landscape in the region.
Access to
Innovative Medicines
Read our latest commissioned research, conducted by IQVIA in Chile, Colombia and Peru, on Access to innovative medicines compared to other OECD countries.
Subscribe to our newsletter and receive relevant news about our industry and region.